跳至主要内容
临床试验/NCT04417348
NCT04417348已完成不适用

Expression of Opsins Receptors in Melasma and Its Modification With UV-Visible Light Sunscreen and 0.05% Retinoic Acid.

Universidad Autonoma de San Luis Potosí1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2019年1月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
MASI score

研究概览

简要总结

Melasma is a hyperpigmentation disorder that is probably exacerbated by visible light. Opsin receptors (OPN 1, 2, 3, 4 y 5) were described in the skin, being capable of activating melanogenesis induced by visible light. The aim of this study was to evaluate the expression of OPN in melasma skin and its changes following treatment with UV-Vis filter and 0.05% retinoic acid for 12 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients diagnosed with melasma, of 18 years of age and older, without previous treatment or photoprotection measures within the previous 4 weeks, who had Melasma Activity and Severity Index (MASI) scores higher than 7

排除标准

  • pregnancy or nursing, menopause, coexistence of other pigmentation conditions, heat exposure, regular exercise, diet restriction, consumption of food supplements or any type of drugs (including anti-inflammatories and hormonal treatments) within the previous 2 months, and women who had given birth within 1 year

研究组 & 干预措施

Retinoic Acid

Active Comparator

patients with melasma treated with 0.05% retinoic acid plus UV-Visible light filter

干预措施: Retinoic acid (Drug)

Sunscreen

Placebo Comparator

patients with melasma treated with UV-Visible light filter alone

干预措施: Retinoic acid (Drug)

结局指标

主要结局

MASI score

时间窗: 3 months

Melasma Activity and Severity Index

次要结局

  • Opsin receptors(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Juan Pablo Castanedo-Cazares

Adjunt professor

Universidad Autonoma de San Luis Potosí

研究点 (1)

Loading locations...

相似试验